Showing results (91-100 of 149) with videos related to
Sort By:
Pageof 15
Melanoma Research|January 26, 1999
Clinical experience of fotemustine, cisplatin and high dose tamoxifen in patients with metastatic malignant melanomaK A Semb, S Aamdal, T Bohmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer StudyG Blijham, T Wagener, J Wils, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1991
Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative GroupJ A Wils, H O Klein, D J Wagener, et al.International Journal of Radiation Oncology, Biology, Physics|January 1, 1989
Palliative therapy of inoperable oesophageal carcinoma with radiotherapy and methotrexate: final results of a controlled clinical trialA Roussel, H Bleiberg, O Dalesio, et al.European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patientsBensmaïne, A de Gramont, S Brienza, et al.Anti-Cancer Drugs|February 1, 1995
Optimal combination therapy with Navoban (tropisetron) in patients with incomplete control of chemotherapy-induced nausea and vomiting. The Belgian Navoban GroupS J Van Belle, V F Cocquyt, H Bleiberg, et al.British Journal of Cancer|August 17, 2000
Prognostic factors for tumour response, progression-free survival and toxicity in metastatic colorectal cancer patients given irinotecan (CPT-11) as second-line chemotherapy after 5FU failure. CPT-11 F205, F220, F221 and V222 study groupsG Freyer, P Rougier, R Bugat, et al.European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesilate and granisetron in patients receiving high dose cisplatin chemotherapyB Audhuy, P Cappelaere, M Martin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 27, 2006
Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based populationH Bleiberg, P Autier, F Huet, et al.Tropical Animal Health and Production|August 19, 2007
Supplementation with groundnut haulms for sheep fattening in the West African SahelA A Ayantunde, P Delfosse, S Fernandez-Rivera, et al.Pageof 15